#3849
Is patient's BMI representative of their body composition in neuroendocrine tumors?
Introduction:
Up to 60% of patients with neuroendocrine tumors (NETs) are malnourished. This negatively impacts survival, length of hospital stay, risk of complications, treatment response, fatigue and quality of life. Malnutrition is typically defined by body mass index (BMI) or weight loss, which provides no information on body composition. Research in other cancers has shown sarcopenia is more significant than BMI. Information is lacking on the influence of anthropometric parameters in NETs.
Conference:
Presenting Author:
Bradley E
Authors:
Bradley E,
Shah T,
Keywords:
neuroendocrine,
body composition,
handgrip strength,
mid arm muscle circumference,
#3415
The PEI-Q paradox: Qualitative assessment of exocrine function in NET patients treated with SSAs
Introduction:
Somatostatin-analogues (SSAs) are first-line treatment of unresectable, symptomatic neuroendocrine tumors (NETs), though can cause pancreatic exocrine insufficiency (PEI). PEI symptoms of diarrhoea, bloating, and steatorrhea overlap with those of NETs (carcinoid sequelae), and both have a negative impact on quality of life. The Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) can be used to assess PEI; however, we hypothesise that the score will be unreliable in SSA-induced PEI due to concurrent improvement of carcinoid symptoms.
Conference:
Presenting Author:
Hall L
Authors:
Hall L,
Powell-Brett S,
Thompson O,
Bradley E,
Smith S,
Keywords:
Pancreatic Exocrine Insufficiency (PEI),
Neuroendocrine Tumor (NET),
Patient Reported Outcome,
